Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age.
about
Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancerLow-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma.S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial.Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1Current Development of Anti-Cancer Drug S-1.Fulminating septic shock from Clostridium perfringens in an early breast cancer patient with severe myalgia after docetaxel treatment.
P2860
Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Phase I/II trial with docetaxe ...... cer with consideration to age.
@en
type
label
Phase I/II trial with docetaxe ...... cer with consideration to age.
@en
prefLabel
Phase I/II trial with docetaxe ...... cer with consideration to age.
@en
P2093
P1476
Phase I/II trial with docetaxe ...... ncer with consideration to age
@en
P2093
Bong Hwa Lee
Choong Kee Park
Dae Hyun Yang
Dae Young Zang
Hae Wan Lee
Hun Ho Song
Hyo Jung Kim
Jong Hyeok Kim
Joo Young Jung
Jung Han Kim
P2888
P304
P356
10.1007/S00280-008-0768-9
P577
2008-05-15T00:00:00Z
P6179
1043016655